EMAIL THIS PAGE TO A FRIEND

Analytical and bioanalytical chemistry

Phenotyping of CYP450 in human liver microsomes using the cocktail approach.


PMID 24894520

Abstract

The cocktail approach is an advantageous strategy used to monitor the activities of several cytochromes P450 (CYPs) in a single test to increase the throughput of in vitro phenotyping studies. In this study, a cocktail mixture was developed with eight CYP-specific probe substrates to simultaneously evaluate the activity of the most important CYPs, namely, CYP1A2, CYP2A6, CYP2B6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and the CYP3A subfamily. After cocktail incubation in the presence of human liver microsomes (HLMs), the eight selected substrates and their specific metabolites were analyzed by ultra-high-pressure liquid chromatography and electrospray ionization quadrupole time-of-flight mass spectrometry. Qualitative and quantitative data were simultaneously acquired to produce an overview of the extended phase I biotransformation routes for each probe substrate in the HLMs and to generate phenotypic profiles of various HLMs. A comparison of the cocktail strategy with an individual substrate assay for each CYP produced similar results. Moreover, the cocktail was tested on HLMs with different allelic variants and/or in the presence of selective inhibitors. The results were in agreement with the genetic polymorphisms of the CYPs and the expected effect of the alterations. All of these experiments confirmed the reliability of this cocktail assay for phenotyping of the microsomal CYPs.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

H28807
1-(2-Hydroxyethyl)piperazine, 98%
C6H14N2O
A7085
Acetaminophen, BioXtra, ≥99.0%
C8H9NO2
A3035
Acetaminophen, analytical standard
C8H9NO2
A5000
Acetaminophen, meets USP testing specifications, 98.0-102.0%, powder
C8H9NO2
1003009
Acetaminophen, United States Pharmacopeia (USP) Reference Standard
C8H9NO2
PHR1005
Acetaminophen, Pharmaceutical Secondary Standard; Certified Reference Material
C8H9NO2
A-064
Acetaminophen solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
C8H9NO2
B102
Bupropion hydrochloride, ≥98% (HPLC), solid
C13H18ClNO · HCl
1078733
Bupropion hydrochloride, United States Pharmacopeia (USP) Reference Standard
C13H18ClNO · HCl
C4397
Chlorzoxazone
C7H4ClNO2
72609
Coumarin, certified reference material, TraceCERT®
C9H6O2
C4261
Coumarin, ≥99% (HPLC)
C9H6O2
W526509
Coumarin, ≥98%
C9H6O2
01260595
Coumarin, primary reference standard
C9H6O2
Y0000438
Coumarin, European Pharmacopoeia (EP) Reference Standard
C9H6O2
1180503 Dextromethorphan, United States Pharmacopeia (USP) Reference Standard
C18H25NO
UC205
Dextrorphan
C17H23NO
F8514
Flurbiprofen, cyclooxygenase inhibitor
C15H13FO2
F0285200
Flurbiprofen, European Pharmacopoeia (EP) Reference Standard
C15H13FO2
PHR1499
Flurbiprofen, Pharmaceutical Secondary Standard; Certified Reference Material
C15H13FO2
K1003
Ketoconazole, ≥98% (HPLC)
C26H28Cl2N4O4
PHR1385
Ketoconazole, Pharmaceutical Secondary Standard; Certified Reference Material
C26H28Cl2N4O4
1356508
Ketoconazole, United States Pharmacopeia (USP) Reference Standard
C26H28Cl2N4O4
K0600000
Ketoconazole, European Pharmacopoeia (EP) Reference Standard
C26H28Cl2N4O4
UC280
Ketoconazole
C26H28Cl2N4O4
P0300000
Paracetamol, European Pharmacopoeia (EP) Reference Standard
C8H9NO2
77440
Phenacetin, ≥98.0% (HPLC)
C10H13NO2
PHR1249
Phenacetin
C10H13NO2
PHR1094
Phenacetin melting point standard, Pharmaceutical Secondary Standard; Certified Reference Material
C10H13NO2
1514008
Phenacetin Melting Point Standard, United States Pharmacopeia (USP) Reference Standard
C10H13NO2